BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7237891)

  • 1. Decreased quinidine plasma protein binding during hemodialysis.
    Kessler KM; Perez GO
    Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood collection techniques, heparin and quinidine protein binding.
    Kessler KM; Leech RC; Spann JF
    Clin Pharmacol Ther; 1979 Feb; 25(2):204-10. PubMed ID: 759074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma.
    Nilsen OG; Storstein L; Jacobsen S
    Biochem Pharmacol; 1977 Feb; 26(3):229-35. PubMed ID: 843392
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of renal transplantation on plasma protein binding.
    Affrime MB; Blecker DL; Lyons PJ; Pitone JM; Swartz CD; Lowenthal DT
    J Dial; 1979; 3(2-3):207-18. PubMed ID: 389974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on digitalis. VI. The effect of heparin on serum protein binding of digitoxin and digoxin.
    Storstein L; Janssen H
    Clin Pharmacol Ther; 1976 Jul; 20(1):15-23. PubMed ID: 1277722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical implication of changing unbound quinidine levels.
    Kessler KM; Wozniak PM; McAuliffe D; Terracall E; Kozlovskis P; Mahmood I; Zaman L; Trohman RG; Castellanos A; Myerburg RJ
    Am Heart J; 1989 Jul; 118(1):63-9. PubMed ID: 2741797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of authentic and artifactual effect of circulating heparin on drug protein binding.
    Dubé LM; Davies RF; Beanlands DS; Mousseau N; Beaudoin N; Chan B; Ho-Ngoc A; McGilveray IJ
    Biopharm Drug Dispos; 1989; 10(1):55-68. PubMed ID: 2923961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the apparent protein binding of quinidine.
    Guentert TW; Oie S
    J Pharm Sci; 1982 Mar; 71(3):325-8. PubMed ID: 7069591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of several factors that intervene in hemodialysis on serum levels of triglycerides and free fatty acids.
    Pérez-García A; Bretó M; Alvarińo J; Alegre B; Cruz JM
    Clin Nephrol; 1979 Jul; 12(1):14-7. PubMed ID: 477051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
    Verbeeck RK; De Schepper PJ
    Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of relationship between serum free fatty acids and impaired plasma protein binding of diphenylhydantoin in chronic renal failure.
    Odar-Cederlöf I; Borgå O
    Eur J Clin Pharmacol; 1976; 10(6):403-5. PubMed ID: 1001355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact.
    De Smet R; Van Kaer J; Liebich H; Lesaffer G; Verstraete A; Dhondt A; Duym P; Lameire N; Vanholder R
    Clin Chem; 2001 May; 47(5):901-9. PubMed ID: 11325895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency.
    Pérez-Mateo M; Erill S
    Eur J Clin Pharmacol; 1977 Mar; 11(3):225-31. PubMed ID: 856605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic variability of binding of antiarrhythmic drugs during the evolution of acute myocardial infarction.
    Kessler KM; Kissane B; Cassidy J; Pefkaros KC; Kozlovskis P; Hamburg C; Myerburg RJ
    Circulation; 1984 Sep; 70(3):472-8. PubMed ID: 6744551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinidine and dihydroquinidine interactions in human plasma.
    Ueda CT; Makoid MC
    J Pharm Sci; 1979 Apr; 68(4):448-50. PubMed ID: 438966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of the plasma protein binding of theophylline in health.
    Buss D; Leopold D; Smith AP; Routledge PA
    Br J Clin Pharmacol; 1983 Apr; 15(4):399-405. PubMed ID: 6849774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.